Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Clin Genitourin Cancer ; 22(6): 102206, 2024 Aug 14.
Article in English | MEDLINE | ID: mdl-39236508

ABSTRACT

OBJECTIVES: In the era of artificial intelligence, almost half of the patients use the internet to get information about their diseases. Our study aims to demonstrate the reliability of the information provided by artificial intelligence chatbots (AICs) about urogenital cancer treatments. METHODS: The most frequently searched keyword about prostate, bladder, kidney, and testicular cancer treatment via Google Trends was asked to 3 different AICs (ChatGPT, Gemini, Copilot). The answers were evaluated by 5 different examiners in terms of readability, understandability, actionability, reliability, and transparency. RESULTS: The DISCERN score evaluation indicates that ChatGPT and Gemini provided moderate quality information, while Copilot's quality was low. (Total DISCERN scores; 41, 42, 35, respectively). PEMAT-P Understandability scores were low (40%) and PEMAT-P Actionability scores were moderate only for Gemini (60%) and low for the others (40%). Their readability according to the Coleman-Liau index was above the college level (16.9, 17.2, 16, respectively). CONCLUSIONS: In the era of artificial intelligence, patients will inevitably use AICs due to their easy and fast accessibility. However, patients need to recognize that AICs do not provide stage-specific treatment options, but only moderate-quality, low-reliability information about the disease, as well as information that is very difficult to read.

2.
Fr J Urol ; 34(4): 102607, 2024 Mar 15.
Article in English | MEDLINE | ID: mdl-38431081

ABSTRACT

PURPOSE: The aim of this study was to investigate the compliance with follow-up in patients receiving adjuvant chemotherapy (ACT) for testicular cancer at two academic hospitals. MATERIALS AND METHODS: The study analyzed 104 patients with testicular tumors who had undergone surgery at least a year before and received ACT between March 2017 to March 2022. The mean follow-up was 29.2±16.2 (12-73) months. Patients were classified as fully compliant (100% compliance), moderately compliant (50-99%), poorly compliant (1-49%), and non-compliant (no attendance) according to their compliance with the follow-up schedule. RESULTS: At the end of the first year, 76% of patients were fully compliant. By the end of the second year, this number dropped to 50%. Furthermore, 25% of patients were identified as non-compliant in the second year and only 4.3% in the third year. When comparing patients who were compliant and non-compliant at first- and second-year follow-up, no statistically significant difference was found according to age, tumor size, disease stage, or ACT regimen (P=0.938, P=0.784, P=0.867, and P=0.282, respectively). CONCLUSION: This study showed that full compliance with follow-up gradually decreased over the years and that the factors examined were not able to predict this decrease. Prospective studies can help design individualized education and follow-up programs, considering each patient's tumor stage.

3.
Prostate Int ; 10(4): 218-223, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36570650

ABSTRACT

Purpose: Questionnaire forms (QFs) are used in the evaluation of all patients presenting with lower urinary tract symptoms (LUTSs). Our study aims to investigate the compatibility of the three QFs with each other and to investigate the relationship between education level and complete completion of these forms. Materials and methods: A total of 224 patients between February 2018 and February 2019 were included. The patients were divided into 3 groups as primary, intermediate, and advanced according to their education level and the patients who gave incomplete answers to the questions were determined. Results: The mean age of the patients was 61.0 ± 7.57(45-85), International Prostate Symptom Score (IPSS) value was 16.2 ± 8.3(1-35), the international incontinence form-male lower urinary tract symptoms (ICIQ-MLUTS) value was 16.5 ± 7.9(0-38), the visual prostate symptom score (VPSS) value was 9.9 ± 3.0(3-16). There was a significant correlation between the three QFs (P < 0.05). The correlation between IPSS and ICIQ-MLUTS was strong (r = 0.745). The incomplete response rate was 32.1% (n = 72) in ICIQ-MLUTS, 16.5% (n = 37) in VPSS, and 10.7% (n = 24) in IPSS (P < 0.05). The incomplete response rate was not affected by education. The rate of patients who could be questioned with ICIQ-MLUTS but not with the other two QFs varied between 12.9% and 85.2%, depending on the symptoms. Conclusions: Each QF has its advantages and disadvantages. The strong correlation between IPSS and ICIQ-MLUTS found in our study indicates that these tools can be used interchangeably in daily clinical practice. ICIQ-MLUTS can evaluate symptoms that are not present in other QFs. In the evaluation of illiterate patients, VPSS should be used without any alternative.

4.
Int Urol Nephrol ; 40(2): 453-60, 2008.
Article in English | MEDLINE | ID: mdl-18368506

ABSTRACT

BACKGROUND: Renal ischemia/reperfusion (I/R) injury is a major cause of acute renal failure. Silymarin is extracted from Silybum marianum and Cynara cardunculus seeds and fruits. The aim of this study is to investigate whether silymarin administration prevents the damage induced by I/R in rat kidneys. MATERIALS AND METHODS: Thirty male Wistar rats were randomly divided into five experimental groups (n = 6, each) as follows; control group, sham-operated group, I/R group, silymarin group, and I/R + silymarin group. In the I/R and I/R + silymarin groups, both renal arteries were occluded using nontraumatic microvascular clamps for 45 min. Then, at the end of 24 h of reperfusion, the animals were killed. Kidney function tests, the serum and tissue antioxidant enzymes and oxidant products were determined. RESULTS: Animals that were subjected to I/R exhibited significant increase in serum urea, creatinine, and cystatin C levels compared with the rats treated with silymarin prior to the I/R process (P < 0.001). The serum enzymatic activities of superoxide dismutase and glutathione peroxidase significantly decreased in the I/R group; however, this reduction was significantly improved by the treatment with silymarin (P < 0.001 and P < 0.05, respectively). Renal I/R produced a significant increase in serum and tissue malondialdehyde, nitric oxide, and protein carbonyl as compared with controls. Treatment with silymarin resulted in significant reduction in these markers (P < 0.001). CONCLUSION: Based on our findings, silymarin protects the kidneys against I/R injury. This finding may provide a basis for the development of novel therapeutic strategies for protection against the damages caused by I/R.


Subject(s)
Antioxidants/pharmacology , Kidney/drug effects , Plant Extracts/pharmacology , Reperfusion Injury/prevention & control , Silymarin/pharmacology , Animals , Antioxidants/therapeutic use , Cystatin C , Cystatins/blood , Kidney/blood supply , Kidney/enzymology , Kidney Tubules/pathology , Male , Necrosis , Phytotherapy , Plant Extracts/therapeutic use , Rats , Rats, Wistar , Silymarin/therapeutic use
5.
J Emerg Med ; 33(2): 127-9, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17692761

ABSTRACT

Rupture of the urinary collecting system associated with peripelvic extravasation of the urine is an unusual condition and commonly associated with obstructing calculus. We report a patient, recently given chemotherapy due to lymphoma, with acute abdomen symptoms. He had a renal pelvis rupture with perirenal extravasation of urine, an uncommon condition due to a stone in the ureter. Diagnosis was suspected on serial ultrasonography, and confirmed by computed tomograhy. Diagnosis, follow-up, and therapeutic approach are discussed.


Subject(s)
Abdomen, Acute/etiology , Kidney Calculi/complications , Kidney Pelvis/pathology , Ureteral Diseases/complications , Drug-Related Side Effects and Adverse Reactions , Humans , Kidney Calculi/diagnostic imaging , Kidney Pelvis/diagnostic imaging , Male , Middle Aged , Rupture, Spontaneous , Tomography, X-Ray Computed , Ultrasonography
6.
Clin Interv Aging ; 12: 437-444, 2017.
Article in English | MEDLINE | ID: mdl-28280316

ABSTRACT

BACKGROUND: Erectile dysfunction (ED) is common in older men with chronic kidney disease. Magnesium is essential for metabolism of nitric oxide which helps in penile erection. There is little information available about the influence of serum magnesium on ED. The aim of the study was to assess the influence of hypomagnesemia on ED in elderly chronic kidney disease patients. SUBJECTS AND METHODS: A total of 372 patients aged 65-85 years, with an estimated glomerular filtration rate of 60-15 mL/min/1.73 m2, were divided into two groups according to serum magnesium levels: hypomagnesemia, n=180; and normomagnesemia, n=192. ED was assessed through the International Index of Erectile Function-5. Hypomagnesemia is defined as serum magnesium <1.8 mg/dL. RESULTS: The prevalence of ED was higher among hypomagnesemic subjects compared to that among normomagnesemics (93.3% vs 70.8%, P<0.001). Severe ED (62.8% vs 43.8%, P=0.037), mild-to-moderate ED (12.2% vs 5.2%, P=0.016), abdominal obesity (37.2% vs 22.9%, P=0.003), metabolic syndrome (38.4% vs 19.2%, P=0.026), proteinuria (0.83±0.68 vs 0.69±0.48 mg/dL, P=0.023), and C-reactive protein (6.1±4.9 vs 4.1±3.6 mg/L, P<0.001) were high; high-density lipoprotein cholesterol (48.8±14.0 vs 52.6±13.5 mg/dL, P=0.009), and albumin (4.02±0.53 vs 4.18±0.38 g/dL, P=0.001) were low in the hypomagnesemia group. Serum magnesium ≤1.85 mg/dL was the best cutoff point for prediction of ED. Hypomagnesemia (relative risk [RR] 2.27), age ≥70 (RR 1.74), proteinuria (RR 1.80), smoking (RR 21.12), C-reactive protein (RR 1.34), abdominal obesity (RR 3.92), and hypertension (RR 2.14) were predictors of ED. CONCLUSION: Our data support that ED is related to hypomagnesemia in elderly patients with moderately to severely reduced kidney function.


Subject(s)
Erectile Dysfunction/epidemiology , Hypercalciuria/epidemiology , Nephrocalcinosis/epidemiology , Renal Insufficiency, Chronic/epidemiology , Renal Tubular Transport, Inborn Errors/epidemiology , Aged , Aged, 80 and over , C-Reactive Protein/analysis , Cross-Sectional Studies , Glomerular Filtration Rate , Humans , Lipids/blood , Male , Obesity, Abdominal/epidemiology , Prospective Studies , Trauma Severity Indices
7.
Acta Histochem ; 118(3): 263-70, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26920108

ABSTRACT

In this study, we investigated the protective effect of selenium (Se) on cisplatin (Cis) induced testicular damage using histopathological, immunohistochemical and biochemical approaches. Twenty-one male Wistar rats were equally divided into three groups of seven rats each: control (C), Cis, and Cis+Se. Cis and Cis+Se group rats received Cis at a dose of 12mg/kg b.w./day, intraperitoneally for 3 consecutive days. Cis+Se group rats received selenium via oral gavage 3mg/kg/day (twice-a day as 1.5mg/kg) until 11th consecutive days starting at 5 days before cisplatin injection. C group received only 0.9% NaCl intraperitoneally and orally at same time and at equal volume. After the treatment, the histopathological, immunohistochemical and biochemical examinations were performed. In seminiferous tubules of Cis treated rats were observed the most consistent findings characterized with vacuolization, desquamation, disorganization, and also was a considerable reduction in elongated spermatids, however the Cis+Se group exhibited improved histopathologic changes. In the immunohistochemical examinations, caspase-3 immunopositive cells displayed higher in the Cis group according to C and Cis+Se groups. Bcl-2 and NF-κB staining revealed a moderate number in the C group and significantly fewer in the Cis group compared to the Cis+Se groups. Additionally, MDA levels were also significantly increased in the Cis group in comparison to Control group, but pretreatment with selenium prevented elevation of MDA levels significantly in Cis+Se group rats. This study indicates that Cis-treatment induced testicular apoptosis and lipid peroxidation, and combined treatment with selenium prevented severity of the toxicity in rats.


Subject(s)
Antineoplastic Agents/toxicity , Antioxidants/pharmacology , Cisplatin/toxicity , Selenium/pharmacology , Testis/drug effects , Animals , Apoptosis , Lipid Peroxidation , Male , Oxidative Stress , Rats, Wistar , Testis/pathology
8.
Curr Eye Res ; 40(10): 1068-72, 2015.
Article in English | MEDLINE | ID: mdl-25495762

ABSTRACT

BACKGROUND: To evaluate the effects of selective α1A-adrenoceptor antagonist tamsulosin hydrochloride on choroidal thickness using enhanced depth imaging spectral-domain optical coherence tomography (EDI-OCT). METHODS: This is a prospective observational study including 29 eyes of 29 patients with newly diagnosed benign prostatic hyperplasia. Choroidal thickness and retrobulbar ocular blood flow measurements were performed at baseline and after 3 months of treatment. Results were analyzed by the masked observer. RESULTS: The mean subfoveal choroidal thickness (275.8-291.9 µm) and thicknesses 750 µm nasal (257.9-270.4 µm) and 750 µm temporal (262.4-277.0 µm) to the fovea were significantly increased after 3 months of treatment (p < 0.001). No statistically significant change was found in retrobulbar ocular blood flow. CONCLUSIONS: Tamsulosin causes a significant increase in EDI-OCT-based choroidal thickness measurements. This increase might be associated with choroidal vasodilation in consequence of blockade of sympathetic α1A-adrenoceptors, which is critical for the maintenance of vascular tone and resistance in the choroidal vascular architecture. This should be kept in mind when choroidal disease and its response to treatment are followed by EDI-OCT imaging.


Subject(s)
Adrenergic alpha-1 Receptor Antagonists/therapeutic use , Choroid/pathology , Prostatic Hyperplasia/drug therapy , Sulfonamides/therapeutic use , Tomography, Optical Coherence , Administration, Oral , Aged , Blood Flow Velocity , Choroid/blood supply , Ciliary Arteries/physiology , Humans , Male , Middle Aged , Ophthalmic Artery/physiology , Organ Size , Prospective Studies , Prostatic Hyperplasia/physiopathology , Regional Blood Flow , Retinal Artery/physiology , Tamsulosin , Ultrasonography, Doppler, Color
9.
Int Urol Nephrol ; 47(5): 823-9, 2015 May.
Article in English | MEDLINE | ID: mdl-25812822

ABSTRACT

PURPOSE: Varenicline is a new most effective drug for smoking cessation. Its effect on kidney functions remains unclear. This study purposed to investigate whether varenicline causes nephrotoxicity in rats. METHODS: Fifteen rats were randomly assigned to three groups: control, 0.0125 mg kg(-1) varenicline and 0.025 mg kg(-1) varenicline (single dose for 3 days, i.p.). Before and after experimental period, serum neutrophil gelatinase-associated lipocalin, creatinine and urea levels were measured. Total oxidant and antioxidant status were measured in kidney homogenates. Histological examination was performed in kidney. RESULTS: The nephrotoxic effects of varenicline were detected by histopathological and biochemical examinations in the varenicline treatment groups. No change was observed in the control group. CONCLUSIONS: These findings firstly indicate that a 3-day varenicline treatment causes nephrotoxic effects in rats.


Subject(s)
Acute Kidney Injury/chemically induced , Acute Kidney Injury/pathology , Nicotinic Agonists/adverse effects , Tobacco Use Cessation Devices/adverse effects , Varenicline/adverse effects , Acute Kidney Injury/blood , Acute-Phase Proteins , Animals , Antioxidants/analysis , Creatinine/blood , Kidney/chemistry , Lipocalin-2 , Lipocalins/blood , Male , Oxidants , Proto-Oncogene Proteins/blood , Rats , Rats, Wistar , Urea/blood
10.
Int Urol Nephrol ; 35(4): 489-90, 2003.
Article in English | MEDLINE | ID: mdl-15198150

ABSTRACT

We are presenting a 68-year-old female patient who was diagnosed to have a complete ureteral duplication and adenocarcinoma in the ureter which drained the upper moiety of the right kidney.


Subject(s)
Adenocarcinoma/complications , Ureteral Neoplasms/complications , Adenocarcinoma/surgery , Aged , Female , Humans , Nephrectomy/methods , Treatment Outcome , Ureteral Diseases/complications , Ureteral Diseases/congenital , Ureteral Neoplasms/surgery , Urologic Surgical Procedures/methods
11.
Urol J ; 11(4): 1825-8, 2014 Sep 06.
Article in English | MEDLINE | ID: mdl-25194084

ABSTRACT

PURPOSE: To evaluate the predictive power of luteinizing hormone (LH), follicle-stimulating hormone (FSH), testosterone, testicular biopsy histology and male age were evaluated with respect to the success of sperm retrieval in a microdissection testicular sperm extraction (microTESE) procedure, pregnancy and live birth rates. MATERIALS AND METHODS: We examined the data of 131 infertile men with non-obstructive azoospermia, who have undergone microTESE operation. The men were classified into two groups based on serum follicle-stimulating hormone (FSH) levels ≤ 15 mIU/mL (group 1) and > 15 mIU/mL (group 2). RESULTS: Group 1 consisted of 59 patients (mean age 36.2 ± 6.2 years) and group 2 consisted of 72 (mean age 38.8 ± 7.4 years) patients. Sperm retrieval and pregnancy rates were 66.1% and 16.9% in normal FSH group, respectively. These parameters were higher than those of men with FSH > 15 (43% and 8.3%, respectively). Only 128 patients had histopathological diagnosis. Sperm was retrieved from 12/30 (40%) patients with maturation arrest, 9/29 (31.03%) patients with seminiferous tubules atrophy, 14/40 (35%) patients with sertoli cell only syndrome and 13/13 (100%) of patients with hypospermatogenesis. There was no statistically significant difference in pathological diagnosis between pregnancy and live birth rates. CONCLUSION: These results demonstrate that there is a significant difference with sperm retrieval, pregnancy rates and live birth rates comparing the FSH levels. Histopathological findings did not associate with successful microTESE, pregnancy rates and live birth rates.


Subject(s)
Azoospermia/blood , Follicle Stimulating Hormone/blood , Pregnancy Rate , Sperm Retrieval , Adult , Age Factors , Azoospermia/pathology , Azoospermia/therapy , Biopsy , Female , Humans , Live Birth , Male , Microdissection , Middle Aged , Oligospermia/pathology , Pregnancy , Sertoli Cell-Only Syndrome/pathology , Testis/pathology
12.
Article in English | MEDLINE | ID: mdl-16941068

ABSTRACT

Untreated asymptomatic bacteriuria has been associated with acute pyelonephritis, which may have a role in many maternal and fetal complications. Acute pyelonephritis in pregnancy is related to anemia, septicemia, transient renal dysfunction, and pulmonary insufficiency. A randomized study was conducted to assess the clinical and microbiological efficacy of a single dose of fosfomycin trometamol for the treatment of asymptomatic bacteriuria in the second trimester of pregnancy compared with a 5-day regimen of cefuroxime axetyl. Forty-four women received fosfomycin trometamol and 40 women received cefuroxime axetyl. There were no statistically significant differences between both groups regarding the mean age and mean duration of pregnancy. Therapeutic success was achieved in 93.2% of the patients treated with fosfomycin trometamol vs 95% of those treated with cefuroxime axetyl. A single dose of fosfomycin trometamol is a safe and effective alternative in the treatment of asymptomatic urinary tract infections in the second trimester of pregnancy.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Bacteriuria/drug therapy , Fosfomycin/administration & dosage , Pregnancy Complications, Infectious/drug therapy , Pregnancy Trimester, Second , Adult , Age Factors , Cefuroxime/administration & dosage , Cefuroxime/analogs & derivatives , Drug Administration Schedule , Escherichia coli Infections/drug therapy , Female , Humans , Pregnancy , Safety , Single-Blind Method , Treatment Outcome
13.
Article in English | MEDLINE | ID: mdl-15834509

ABSTRACT

Urethral caruncles are considered as benign tumors. They need to be treated surgically; specimens should carefully be evaluated for the presence of any malignancy. We are presenting a 57-year-old female patient with a urethral lesion that looks like caruncle, but histopathologic examination of the excised lesion was reported as urethral adenocarcinoma.


Subject(s)
Adenocarcinoma/diagnosis , Urethral Neoplasms/diagnosis , Adenocarcinoma/epidemiology , Adenocarcinoma/pathology , Comorbidity , Female , Humans , Middle Aged , Urethral Neoplasms/epidemiology , Urethral Neoplasms/pathology , Urinary Bladder Diseases/epidemiology , Urinary Bladder Diseases/surgery
14.
J Urol ; 174(6): 2260-2, discussion 2262-3, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16280794

ABSTRACT

PURPOSE: In this prospective study we evaluated the incidence of bladder perforation after transurethral bladder tumor resection. MATERIALS AND METHODS: A total of 36 patients (33 male, 3 female, mean age +/- SD 65.6 +/- 11.43 [range 26 to 81]) with a solid mass in the bladder (mean 20.3 +/- 8.7 mm, range 5 to 40) were included in the study. Transurethral resections were performed with a 24Fr resectoscope. After the procedure an 18Fr Foley catheter was inserted into the bladder and 400 ml of 1/4 saline diluted contrast solution was instilled under gravity from 60 cm above the bladder. Complete filling and post-drainage radiographs were taken and examined for any evidence of extravasation. Regular evaluations with cystoscopy and ultrasound/computerized tomography were done to detect possible tumor recurrence and perivesical seeding. RESULTS: Histopathological examination of the tumors showed transitional cell carcinoma in 35 patients and chronic eosinophilic cystitis in 1. Review of the cystograms revealed various degrees of extraperitoneal contrast extravasation around the resected area in 21 patients (58.3%). The only statistically significant difference between patients with and without extravasation was in tumor size (logistic stepwise regression p = 0.030,) among factors tested including patient age and localization, number of foci, tumor grade and stage. No apparent clinical problems requiring medical or surgical intervention other than urethral catheterization developed and no evidence of extravesical tumor seeding as per ultrasound and/or computerized tomography was seen during a mean followup of 21.9 months (range 7 to 40). CONCLUSIONS: The extravasation of urine (asymptomatic perforation) after transurethral bladder tumor resection may occur much more frequently than believed or reported. It seems that this extravasation does not impose a significant risk of extravesical tumor seeding.


Subject(s)
Cystectomy/adverse effects , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Urethra/surgery , Urinary Bladder Neoplasms/surgery , Urinary Bladder/injuries , Adult , Aged , Aged, 80 and over , Carcinoma, Transitional Cell/surgery , Cystectomy/methods , Cystitis, Interstitial/surgery , Female , Follow-Up Studies , Humans , Incidence , Male , Middle Aged , Multivariate Analysis , Neoplasm Staging , Postoperative Complications/diagnosis , Prospective Studies , Rupture/etiology , Tomography, X-Ray Computed , Treatment Outcome , Urinary Bladder Neoplasms/diagnosis
15.
Scand J Urol Nephrol ; 38(6): 521-2, 2004.
Article in English | MEDLINE | ID: mdl-15841790

ABSTRACT

We report the case of a patient with a recurrent membranous urethral stricture who was treated with temporary implantation of a UroLume endoprosthesis and recovered completely, without any sphincteric insufficiency or stricture recurrence, during a 1-year follow-up period.


Subject(s)
Stents , Urethral Stricture/surgery , Urodynamics/physiology , Urologic Surgical Procedures, Male/instrumentation , Wound Healing/physiology , Cystoscopy , Follow-Up Studies , Humans , Male , Middle Aged , Rheology , Secondary Prevention , Treatment Outcome , Urethral Stricture/diagnosis , Urethral Stricture/physiopathology , Urography
SELECTION OF CITATIONS
SEARCH DETAIL